Perrigo reported $697.1M in Trade Debtors for its fiscal quarter ending in March of 2026.





Trade Debtors Change Date
AbbVie USD 12.48B 110M Mar/2026
Abbott USD 11.22B 655M Mar/2026
Bayer EUR 18.55B 4.36B Mar/2026
Bristol-Myers Squibb USD 13.83B 535M Jun/2026
Coherus Biosciences USD 18.42M 232.08M Dec/2025
Corcept Therapeutics USD 76.92M 37.85M Jun/2026
Dr.Reddys Laboratories INR 124.42B 19.68B Jun/2026
Eli Lilly USD 23.48B 2.3B Jun/2026
J&J USD 22.54B 1.21B Mar/2026
Merck USD 12.21B 435M Mar/2026
Nestle CHF 11.26B 686M Jun/2026
Pacira USD 132.42M 6.78M Jun/2026
Perrigo USD 697.1M 84.3M Mar/2026
Pfizer USD 16.19B 19M Jun/2026
Phibro Animal Health USD 215.87M 2.02M Dec/2025
Prestige Brands USD 187.36M 4.56M Jun/2026
Reckitt Benckiser GBP 2.14B 117M Dec/2024
Sanofi EUR 492M 10M Jun/2026
Supernus Pharmaceuticals USD 211.66M 29.47M Jun/2026
Teva Pharmaceutical Industries USD 3.49B 100M Jun/2026
Xeris Pharmaceuticals USD 56.29M 5.24M Mar/2026
Zoetis USD 1.57B 65M Jun/2026